Lumibird SA (EPA:LBIRD)
France · Delayed Price · Currency is EUR 21.50
+0.10 (0.47%)
At close: Mar 13, 2026
Lumibird Revenue
In the year 2025, Lumibird had annual revenue of 225.60M EUR with 7.40% growth. Lumibird had revenue of 108.28M in the half year ending June 30, 2025, with 9.97% growth.
Revenue
225.60M
Revenue Growth
+7.40%
P/S Ratio
2.10
Revenue / Employee
211.24K
Employees
1,068
Market Cap
473.46M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 225.60M | 15.54M | 7.40% |
| Dec 31, 2024 | 210.06M | 3.50M | 1.70% |
| Dec 31, 2023 | 206.55M | 12.26M | 6.31% |
| Dec 31, 2022 | 194.29M | 27.91M | 16.77% |
| Dec 31, 2021 | 166.39M | 36.88M | 28.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 46.72B |
| EssilorLuxottica Société anonyme | 28.49B |
| Ipsen | 3.93B |
| Sartorius Stedim Biotech | 2.97B |
| LNA Santé | 863.42M |
| Vetoquinol | 532.39M |
| Boiron | 504.86M |
| Equasens Société anonyme | 224.73M |